OVID . The company’s stock price has collected -2.00% of loss in the last five trading sessions. Why Ovid Therapeutics Stock Is Imploding Today. Ovid Therapeutics Inc. (NASDAQ:OVID) went down by -7.80% from its latest closing price compared to the recent 1-year high of $9.40. OVID Stock Price Chart Interactive Chart > OVID Price/Volume Stats. Daily Weekly. Current price $3.43 : 52-week high $9.40 : Prev. Ovid Therapeutics Inc. (NASDAQ:OVID)’s beta value is holding at 1.86, while the average true range (ATR) indicator is currently reading 0.16. Find market predictions, OVID financials and market news. Their forecasts range from $4.00 to $40.00. GROUP LEADERSHIP. is … View the basic OVID option chain and compare options of Ovid Therapeutics Inc. on Yahoo Finance. Shares of Ovid Therapeutics (NASDAQ: OVID) -- a clinical-stage biotech company -- are down by 55% as of 11:04 a.m. EST on Wednesday, after falling by as much as 56.4% earlier in the day. Ovid Therapeutics News: Why OVID Stock Is Plunging 55% Today InvestorPlace Dec 02, 2020 Ovid Therapeutics misses goal in Angelman syndrome treatment Seeking Alpha Dec 01, 2020 9 Wall Street analysts have issued ratings and price targets for Ovid Therapeutics in the last 12 months. The closing price above is not necessarily indicative of future price … Stock quote and company snapshot for OVID THERAPEUTICS INC (OVID), including profile, stock chart, recent news and events, analyst opinions, and research reports. The firm has a market capitalization of $217.58 million, a P/E ratio of -2.43 and a beta of 1.86. Ovid Therapeutics Inc. (NASDAQ:OVID)’s beta value is holding at 1.83, while the average true range (ATR) indicator is currently reading 0.26. View today's stock price, news and analysis for Ovid Therapeutics Inc. (OVID). Find real-time OVID - Ovid Therapeutics Inc stock quotes, company profile, news and forecasts from CNN Business. The consensus price target for the stock as assigned by Wall Street analysts is $8, meaning bulls need an upside of 113.33% from its current market value. 5:21 EST OVID Stock Quote Delayed 30 Minutes Volume: Previous Close-Market Cap 86.18M PE Ratio-1.97 EPS-1.777157 Volume (Avg. Shares of Ovid Therapeutics (NASDAQ: OVID) -- a clinical-stage biotech company -- are down by 55% as of 11:04 a.m. EST on Wednesday, after falling by as much as 56.4% earlier in the day. If you had invested in Ovid Therapeutics stock at $12.25, your return over the last 3 years would have been -80.24%, for an annualized return of -41.76%. 9 brokers have issued twelve-month price targets for Ovid Therapeutics' shares. View the real-time OVID price chart on Robinhood and decide if you want to buy or sell commission-free. OVID stock was down 55.3% as of noon Wednesday. This suggests a possible upside of 237.9% from the stock's current price. Wall Street Stock Market & Finance report, prediction for the future: You'll find the Ovid Therapeutics share forecasts, stock quote and buy / sell signals below.According to present data Ovid Therapeutics's OVID shares and potentially its market environment have been in bearish … See How IBD Rates . OVID. On average, they anticipate Ovid Therapeutics' stock price to reach $12.57 in the next year. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools. All quotes are in local exchange time. View the latest Ovid Therapeutics Inc. (OVID) stock price, news, historical charts, analyst ratings and financial information from WSJ. The stock has a 50 day moving average price of $2.81 and a 200 day moving average price of $4.76. On the date of publication, William White did not have (either directly or indirectly) any … GET QUOTE $ 3.75. Press Release reported on 12/01/20 that Ovid Therapeutics Announces Phase 3 NEPTUNE Clinical Trial of OV101 for the Treatment of … Shares of OVID stock opened at $3.43 on Friday. The market is probably reacting to Ovid getting a buy rating from an analyst. Investors are … Further, Ovid Therapeutics Inc. (OVID) has a beta value of 1.83, and an average true range (ATR) of 0.3. Considering analysts have assigned the stock a price target range of $4-$16 as the low and high respectively, we find the trailing 12-month average consensus price target to be $8. Their average twelve-month price target is $12.57, predicting that the stock has a possible upside of 240.69%. Considering analysts have assigned the stock a price target range of $4-$16 as the low and high respectively, we find the trailing 12-month average consensus price target to be $8. Ovid Therapeutics Inc () Stock Market info Recommendations: Buy or sell Ovid Therapeutics stock? Medical-Biomed/Biotech Group. The Split Adjustment Factor is a cumulative factor which encapsulates all splits since the date shown above. Get the latest Ovid Therapeutc OVID detailed stock quotes, stock data, Real-Time ECN, charts, stats and more. Shares of Ovid Therapeutics were up by 29.1%, despite the company not reporting any news. To hit the forecast high, the stock’s price needs a +326.67% upsurge from its current level, while the stock would need to … OVID: Get the latest Ovid Therapeutics stock price and detailed information including OVID news, historical charts and realtime prices. The COVID Tracking Project collects and publishes the most complete testing data available for US states and territories. According to analyst projections, OVID’s forecast low is $4 with $16 as the target high. Ovid Therapeutics Inc (OVID) Stock Quote and News . OVID stock quote, chart and news. Real-time last sale data for U.S. stock quotes reflect trades reported through Nasdaq only. A high-level overview of Ovid Therapeutics Inc. (OVID) stock. The high price target for OVID is $40.00 and the low price target for OVID is $4.00. 0.33; 9.65%; Volume: 5.4 Mil . Change the date range, see whether others are buying or selling, read news, get earnings results, and compare Ovid Therapeutics against related stocks people have also bought. Volume % Chg: 125%; Get a Leaderboard Chart for OVID? Ovid Therapeutics Announces Pricing of $32.5 Million of Securities in Concurrent Public Offerings of Common Stock and Preferred Stock Globenewswire Test -26.76% 08:30AM close ... Why Ovid Therapeutics Stock Is Imploding Today. Get the latest Ovid Therapeutics (OVID) stock price quote with real-time news, financials, charts and other important investing information. Ovid Therapeutics stock was originally listed at a price of $12.25 in May 5, 2017. You can buy and sell Ovid Therapeutics (OVID) stock and options and many more commission … Get Ovid Therapeutics, Inc.'s stock price today. Analysts have given the company’s stock an average 52-week price target of $8, forecast between a low of $4 and high of $16. View Ovid Therapeutc OVID investment & stock information. TradingView UK. Vol.) In March and again in June, Ladenburg Thalmann analyst Michael Higgins gave the stock a $20 price target. Get Ovid Therapeutics Inc (OVID:NASDAQ) real-time stock quotes, news, price and financial information from CNBC. Ovid Therapeutics Inc (OVID) - DEVELOPING GENE THERAPEUTICS FOR INHERITED AND ACQUIRED DISORDERS. NOTE: The Closing Price, Day's High, Day's Low, and Day's Volume have been adjusted to account for any stock splits and/or dividends which may have occurred for this security since the date shown above. Ovid Therapeutics has a 52-week low of $1.80 and a 52-week high of $9.40. View live OVID THERAPEUTICS INC chart to track its stock's price action. ----- Michael Higgins, an analyst with Ladenburg Thalmann, reiterated a buy rating on Ovid's stock today. Intraday data delayed at … Find the latest Ovid Therapeutics Inc. (OVID) stock quote, history, news and other vital information to help you with your stock trading and investing. Get the latest Ovid Therapeutics Inc (OVID) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.